Fine specificity of anti-MSP119 antibodies and multiplicity of plasmodium falciparum merozoite surface protein 1 types in individuals in Nigeria with sub-microscopic infection

Malaria Journal

Volumn 9, Issue 1, 2010, Pages

  Ngoundou Landji, Josiane ^a,b   Nwuba, Roseangela I ^b   Anumudu, Chiaka I ^b   Odaibo, Alexander B ^b   Matondo Maya, Wenceslas D ^c,d   Awobode, Henrietta O ^b   Okafor, Christian M ^b,f   Morenikeji, Olajumoke A ^b   Asinobi, Adanze ^b   Nwagwu, Mark ^b   Holder, Anthony A ^g   Ntoumi, Francine ^d,e  

^a UNIVERSITÉ DES SCIENCES ET TECHNIQUES DE MASUKU   (Gabon)

^b UNIVERSITY OF IBADAN   (Nigeria)

^c Hpital Albert Schweitzer   (Gabon)

^d UNIVERSITY OF TÜBINGEN   (Germany)

^e UNIVERSITÉ MARIEN NGOUABI   (Congo)

^f Northwestern University   (United States)

^g NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; MEROZOITE SURFACE PROTEIN 1; MEROZOITE SURFACE PROTEIN 1(19) ANTIBODY; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 12.10; MONOCLONAL ANTIBODY 12.18; PROTEIN ANTIBODY; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; PROTOZOON ANTIBODY;

ADOLESCENT; ANEMIA; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ANTIGEN BINDING; ARTICLE; CHILD; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; NIGERIA; PHENOTYPE; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD; SCHOOL CHILD; ADULT; BLOOD; GENETICS; HETEROZYGOTE; IMMUNOLOGY; INFANT; ISOLATION AND PURIFICATION; MICROSCOPY; NEWBORN; PARASITEMIA; PARASITOLOGY; POLYMERASE CHAIN REACTION;

ADOLESCENT; ADULT; ANTIBODIES, MONOCLONAL; ANTIBODIES, PROTOZOAN; BLOOD; CARRIER STATE; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALARIA, FALCIPARUM; MALE; MEROZOITE SURFACE PROTEIN 1; MICROSCOPY; NIGERIA; PARASITEMIA; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION;

EID: 77957902068     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-9-287     Document Type: Article

References (41)

1. 19reveals a protective role for invasion inhibitory antibodies. TF de Koning-Ward RA O'Donnell DR Drew R Thomson TP Speed BS Crabb, J Exp Med 2003 198 869 875 10.1084/jem.20030085 12963693
2. Antibodies that inhibit malaria merozoite surface protein-1 processing and erythrocyte invasion are blocked by naturally acquired human antibodies. JA Guevara Patino AA Holder JS McBride MJ Blackman, J Exp Med 1997 186 1689 1699 10.1084/jem.186.10.1689 9362529
3. Antibodies against merozoite surface protein (MSP)-1(19) are a major component of the invasion-inhibitory response in individuals immune to malaria. RA O'Donnell TF de Koning-Ward RA Burt M Bockarie JC Reeder AF Cowman BS Crabb, J Exp Med 2001 193 1403 1412 10.1084/jem.193.12.1403 11413195
4. A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies. MJ Blackman HG Heidrich S Donachie JS McBride AA Holder, J Exp Med 1990 172 379 382 10.1084/jem.172.1.379 1694225
5. Processing of the precursor to the major merozoite surface antigens of Plasmodium falciparum. AA Holder JS Sandhu Y Hillman LS Davey SC Nicholls H Cooper MJ Lockyer, Parasitology 1987 94 199 208 10.1017/S0031182000053889 3295686
6. Fragments of the polymorphic Mr 185,000 glycoprotein from the surface of isolated Plasmodium falciparum merozoites form an antigenic complex. JS McBride HG Heidrich, Mol Biochem Parasitol 1987 23 71 84 10.1016/0166-6851(87)90189-7 2437453
7. Antibodies inhibit the protease-mediated processing of a malaria merozoite surface protein. MJ Blackman TJ Scott-Finnigan S Shai AA Holder, J Exp Med 1994 180 389 393 10.1084/jem.180.1.389 7516416
8. The carboxy-terminus of merozoite surface protein 1: structure, specific antibodies and immunity to malaria. AA Holder, Parasitology 2009 136 1445 1456 10.1017/S0031182009990515 19627632
9. A longitudinal investigation of IgG and IgM antibody responses to the merozoite surface protein-1 19-kiloDalton domain of Plasmodium falciparum in pregnant women and infants: associations with febrile illness, parasitemia, and anemia. OH Branch V Udhayakumar AW Hightower AJ Oloo WA Hawley BL Nahlen PB Bloland DC Kaslow AA Lal, Am J Trop Med Hyg 1998 58 211 219 9502606
10. 19, MSP3 and GLURP with protection from clinical malaria in Ghanaian children. D Dodoo A Aikins KA Kusi H Lamptey E Remarque P Milligan S Bosomprah R Chilengi YD Osei BD Akanmori M Theisen, Malar J 2008 7 142 10.1186/1475-2875-7- 142 18664257
11. Levels of antibody to conserved parts of Plasmodium falciparum merozoite surface protein 1 in Ghanaian children are not associated with protection from clinical malaria. D Dodoo TG Theander JA Kurtzhals K Koram E Riley BD Akanmori FK Nkrumah L Hviid, Infect Immun 1999 67 2131 2137 10225865
12. Human antibodies to the 19 kDa C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 inhibit parasite growth in vitro. AF Egan P Burghaus P Druilhe AA Holder EM Riley, Parasite Immunol 1999 21 133 139 10.1046/j.1365-3024.1999.00209.x 10205793
13. Relationship between maternally derived anti-Plasmodium falciparum antibodies and risk of infection and disease in infants living in an area of Liberia, west Africa, in which malaria is highly endemic. B Hogh NT Marbiah PA Burghaus PK Andersen, Infect Immun 1995 63 4034 4038 7558316
14. Antibodies against Plasmodium falciparum vaccine candidates in infants in an area of intense and perennial transmission: relationships with clinical malaria and with entomological inoculation rates. AY Kitua H Urassa M Wechsler T Smith P Vounatsou NA Weiss PL Alonso M Tanner, Parasite Immunol 1999 21 307 317 10.1046/j.1365-3024.1999.00230.x 10354353
15. Inhibitory antibodies specific for the 19-kilodalton fragment of merozoite surface protein 1 do not correlate with delayed appearance of infection with Plasmodium falciparum in semi-immune individuals in Vietnam. EE Murhandarwati L Wang CG Black DH Nhan TL Richie RL Coppel, Infect Immun 2009 77 4510 4517 10.1128/IAI.00360-09 19620342
16. The human immune response to Plasmodium falciparum includes both antibodies that inhibit merozoite surface protein 1 secondary processing and blocking antibodies. RI Nwuba O Sodeinde CI Anumudu YO Omosun AB Odaibo AA Holder M Nwagwu, Infect Immun 2002 70 5328 5331 10.1128/IAI.70.9.5328-5331.2002 12183594
17. Critical evaluation of different methods for measuring the functional activity of antibodies against malaria blood stage antigens. ES Bergmann-Leitner EH Duncan GE Mullen JR Burge F Khan CA Long E Angov JA Lyon, Am J Trop Med Hyg 2006 75 437 442 16968918
18. The importance of human FcgammaRI in mediating protection to malaria. RS McIntosh J Shi RM Jennings JC Chappel TF de Koning-Ward T Smith J Green M van Egmond JH Leusen M Lazarou J van de Winkel TS Jones BS Crabb AA Holder RJ Pleass, PLoS Pathog 2007 3 5 72 10.1371/journal.ppat.0030072 17511516
19. 19of Plasmodium falciparum. YO Omosun S Adoro CI Anumudu AB Odaibo C Uthiapibull AA Holder M Nwagwu RI Nwuba, Acta Trop 2009 109 208 212 10.1016/j.actatropica.2008.11.011 19081386
20. Inhibitory and blocking monoclonal antibody epitopes on merozoite surface protein 1 of the malaria parasite Plasmodium falciparum. C Uthaipibull B Aufiero SE Syed B Hansen JA Guevara Patino E Angov IT Ling K Fegeding WD Morgan C Ockenhouse B Birdsall J Feeney JA Lyon AA Holder, J Mol Biol 2001 307 1381 1394 10.1006/jmbi.2001.4574 11292349
21. The fine specificity, but not the invasion inhibitory activity, of 19-kilodalton merozoite surface protein 1-specific antibodies is associated with resistance to malarial parasitemia in a cross-sectional survey in The Gambia. PH Corran RA O'Donnell J Todd C Uthaipibull AA Holder BS Crabb EM Riley, Infect Immun 2004 72 6185 6189 10.1128/IAI.72.10.6185-6189.2004 15385530
22. Specificities of antibodies to Plasmodium falciparum merozoite surface protein-1. RI Nwuba SA Adoro AC I AB Odaibo Y Omosun AA Holder M Nwagwu, the 10th International Congress of Parasitology: 2002; Vancouver, Canada 2002 477 486
23. Fine specificity of serum antibodies to Plasmodium falciparum merozoite surface protein, PfMSP-1(19), predicts protection from malaria infection and high-density parasitemia. BA Okech PH Corran J Todd A Joynson-Hicks C Uthaipibull TG Egwang AA Holder EM Riley, Infect Immun 2004 72 1557 1567 10.1128/IAI.72.3.1557-1567.2004 14977962
24. Merozoite surface protein 1, immune evasion, and vaccines against asexual blood stage malaria. AA Holder JA Guevara Patino C Uthaipibull SE Syed IT Ling T Scott-Finnigan MJ Blackman, Parassitologia 1999 41 409 414 10697894
25. 19) can play a protective role against blood-stage Plasmodium falciparum infection in individuals in a malaria endemic area of Africa. CC John RA O'Donnell PO Sumba AM Moormann TF de Koning-Ward CL King JW Kazura BS Crabb, J Immunol 2004 173 666 672 15210830
26. Precise epitope mapping of malaria parasite inhibitory antibodies by TROSY NMR cross-saturation. WD Morgan TA Frenkiel MJ Lock M Grainger AA Holder, Biochemistry 2005 44 518 523 10.1021/bi0482957 15641776
27. Malaria parasite-inhibitory antibody epitopes on Plasmodium falciparum merozoite surface protein-1(19) mapped by TROSY NMR. WD Morgan MJ Lock TA Frenkiel M Grainger AA Holder, Mol Biochem Parasitol 2004 138 29 36 10.1016/j.molbiopara.2004.06.014 15500913
28. Reduced risk of clinical malaria in children infected with multiple clones of Plasmodium falciparum in a highly endemic area: a prospective community study. F al-Yaman B Genton JC Reeder RF Anders T Smith MP Alpers, Trans R Soc Trop Med Hyg 1997 91 602 605 10.1016/S0035-9203(97)90046-8 9463681
29. Complexity of Plasmodium falciparum infections is consistent over time and protects against clinical disease in Tanzanian children. A Farnert I Rooth Svensson G Snounou A Bjorkman, J Infect Dis 1999 179 989 995 10.1086/314652 10068596
30. Identification of a subpopulation of immune Nigerian adult volunteers by antibodies to the circumsporozoite protein of Plasmodium falciparum. M Nwagwu CA Anumudu O Sodeinde CA Ologunde TU Obi RA Wirtz DM Gordon JA Lyon, Am J Trop Med Hyg 1998 58 684 692 9598461
31. High prevalence of the third form of merozoite surface protein-1 in Plasmodium falciparum in asymptomatic children in Gabon. F Ntoumi O Mercereau-Puijalon A Luty A Georges P Millet, Trans R Soc Trop Med Hyg 1996 90 701 702 10.1016/S0035-9203(96)90443-5 9015523
32. Analysis of sequence diversity in the Plasmodium falciparum merozoite surface protein-1 (MSP-1). LH Miller T Roberts M Shahabuddin TF McCutchan, Mol Biochem Parasitol 1993 59 1 14 10.1016/0166-6851(93)90002-F 8515771
33. Expression of the 19-kilodalton carboxy-terminal fragment of the Plasmodium falciparum merozoite surface protein-1 in Escherichia coli as a correctly folded protein. PA Burghaus AA Holder, Mol Biochem Parasitol 1994 64 165 169 10.1016/0166-6851(94)90144-9 8078519
34. Primary structure of the precursor to the three major surface antigens of Plasmodium falciparum merozoites. AA Holder MJ Lockyer KG Odink JS Sandhu V Riveros-Moreno SC Nicholls Y Hillman LS Davey ML Tizard RT Schwarz RR Freeman, Nature 1985 317 270 273 10.1038/317270a0 2995820
35. Phase I safety and immunogenicity trial of FMP1/AS02A, a Plasmodium falciparum MSP-1 asexual blood stage vaccine. CF Ockenhouse E Angov KE Kester C Diggs L Soisson JF Cummings AV Stewart DR Palmer B Mahajan U Krzych N Tornieporth M Delchambre M Vanhandenhove O Ofori-Anyinam J Cohen JA Lyon DG Heppner, Vaccine 2006 24 3009 3017 10.1016/j.vaccine.2005.11.028 16356603
36. Blood stage malaria vaccine eliciting high antigen-specific antibody concentrations confers no protection to young children in Western Kenya. BR Ogutu OJ Apollo D McKinney W Okoth J Siangla F Dubovsky K Tucker JN Waitumbi C Diggs J Wittes E Malkin A Leach LA Soisson JB Milman L Otieno CA Holland M Polhemus SA Remich CF Ockenhouse J Cohen WR Ballou SK Martin E Angov VA Stewart JA Lyon DG Heppner MR Withers, PLoS ONE 2009 4 4708 10.1371/journal.pone.0004708 19262754
37. Frequent and persistent, asymptomatic Plasmodium falciparum infections in African infants, characterized by multilocus genotyping. S Franks KA Koram GE Wagner K Tetteh D McGuinness JG Wheeler F Nkrumah L Ranford-Cartwright EM Riley, J Infect Dis 2001 183 796 804 10.1086/318834 11181157
38. Blood and bone marrow changes in malaria. SN Wickramasinghe SH Abdalla, Baillieres Best Pract Res Clin Haematol 2000 13 277 299 10942626
39. Consequences of multiple infection with Plasmodium falciparum in an area of high endemicity. T Smith I Felger HP Beck M Tanner, Parassitologia 1999 41 247 250 10697863 (Pubitemid 129640260)
40. Impact of subpatent multi-species and multi-clonal plasmodial infections on anaemia in children from Nigeria. J May AG Falusi FP Mockenhaupt OG Ademowo PE Olumese U Bienzle CG Meyer, Trans R Soc Trop Med Hyg 2000 94 399 403 10.1016/S0035-9203(00)90119-6 11127243
41. Different genetic characteristics of Plasmodium falciparum isolates collected during successive clinical malaria episodes in Senegalese children. H Contamin T Fandeur C Rogier S Bonnefoy L Konate JF Trape O Mercereau-Puijalon, Am J Trop Med Hyg 1996 54 632 643 8686784